KENILWORTH, N.J., June 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation is scheduled to announce its sales and earnings results for the second quarter of 2006 on Monday, July 24, 2006.
At 8 a.m. (EDT) on that day, Schering-Plough will conduct a conference call to review the second quarter results. Fred Hassan, Schering-Plough's chairman and CEO, and other members of management will host the conference call.
To listen live to the call, dial 1-877-565-9664 or 1-706-634-5003 and enter conference ID #6243944. A replay of the call will be available starting at approximately 11 a.m. on July 24 through 5 p.m. on July 31. To listen to the replay, dial 1-800-642-1687 or 1-706-645-9291 and enter the conference ID #6243944. A live audio webcast of the conference call also will be available by going to the Investor Relations section of the Schering-Plough corporate Web site, http://www.schering-plough.com/, and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available starting at approximately 11 a.m. on July 24 through 5 p.m. on Aug. 24.
Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 32,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com/.
